Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TWiTCH: Hydroxyurea vs Transfusions in Sickle Cell Anemia
NCT01425307Phase 3Terminated
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Aug 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by Cincinnati Children's Hospital Medical Center. Started Aug 2011; status: terminated.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT01425307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01425307.